股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年10月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: C-Link Squared Limited 呈交日期: 2025年11月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01463 | 說明 | 普通股 | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 4,500,000,000 | HKD | 0.003333333333 | HKD | | 15,000,000 | | 增加 / 減少 (-) | | | 0 | | | HKD | | 0 | | 本月底結存 | | | 4,500,000,000 | HKD | 0.003333333333 | HKD | | ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年9月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: C-Link Squared Limited 呈交日期: 2025年10月3日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01463 | 說明 | 普通股 | | | | | | | | | 法定/註冊股份數目 | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 4,500,000,000 | HKD | 0.003333333333 | HKD | | 15,000,000 | | 增加 / 減少 (-) | | | 0 | | | HKD | | 0 | | 本月底結存 | | | 4,500,000,000 | HKD | 0.003333333333 | HKD | | ...

C-LINK SQUARED LIMITED (Incorporated in the Cayman Islands with limited liability) （於開曼群島註冊成立的有限公司） (Stock code: 1463) （股份代號：1463） Dear Shareholder(s), 29 September 2025 C-Link Squared Limited (the "Company") – Notification of publication of Interim Report 2025 (the "Current Corporate Communication") The Current Corporate Communication of the Company, in both English and Chinese versions, are available on the Company's website (www.clinksquared.com) and The Stock Exchange of Hong Kong Limited's website (www ...

CONTENTS 目錄 | Corporate Information | 公司資料 | 2 | | --- | --- | --- | | Management Discussion and Analysis | 管理層討論及分析 | 5 | | Unaudited Condensed Consolidated Statement of Comprehensive | 未經審核簡明綜合全面收益表 | 27 | | Income | | | | Unaudited Condensed Consolidated Statement of Financial Position | 未經審核簡明綜合財務狀況表 | 29 | | Unaudited Condensed Consolidated Statement of Changes in Equity | 未經審核簡明綜合權益變動表 | 31 | | Unaudited Condensed Consolidated Statement of Cash Flows | 未經審核簡明綜合現金流量表 | 32 | | Notes to Unaudited Condens ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 截至月份: | 2025年8月31日 | | | | 狀態: 新提交 | | --- | --- | --- | --- | --- | --- | | 致：香港交易及結算所有限公司 | | | | | | | 公司名稱: | C-Link Squared Limited | | | | | | 呈交日期: | 2025年9月2日 | | | | | | I. 法定/註冊股本變動 | | | | | | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 (註1) | 是 | | 證券代號 (如上市) | 01463 | 說明 | 普通股 | | | | | 法定/註冊股份數目 | | 面值 | | 法定/註冊股本 | | --- | --- | --- | --- | --- | --- | | 上月底結存 | 4,500,000,000 | HKD | 0.003333333333 | HKD | 15,000,000 | | 增加 / 減少 (-) | | 0 | | HKD | 0 | | ...

智通财经APP讯，C-LINK SQ(01463)发布截至2025年6月30日止6个月中期业绩，集团来自与客户订立合 约的收益5551.1万令吉特，同比增长11.86%;股东应占亏损1.65亿令吉特，同比盈转亏;每股亏损5.75令吉 特仙。 ...

Group 1 - The company C-LINK SQ (01463) reported a mid-term performance for the six months ending June 30, 2025, with revenue from contracts with customers amounting to 55.511 million Malaysian Ringgit, representing a year-on-year growth of 11.86% [1] - The company experienced a loss attributable to shareholders of 165 million Malaysian Ringgit, marking a shift from profit to loss compared to the previous year [1] - The loss per share was reported at 5.75 Malaysian cents [1]

Company Information and Announcement Statement [Announcement Statement](index=1&type=section&id=Announcement%20Statement) C-Link Squared Limited (Stock Code: 1463) announced its unaudited condensed consolidated interim results for the six months ended June 30, 2025, with comparative figures for 2024 - C-Link Squared Limited (Stock Code: 1463) announced its unaudited condensed consolidated interim results for the six months ended June 30, 2025 [2](index=2&type=chunk)[3](index=3&type=chunk) Financial Statements [Unaudited Condensed Consolidated Statement of Comprehensive Income](index=1&type=section&id=Unaudited%20Condensed%20Consolidated%20Statement%20of%20Comprehensive%20Income) The company reported a net loss of **RM165,332 thousand** for the six months ended June 30, 2025, a reversal from a net profit of **RM1,021 thousand** in 2024, mainly due to a substantial increase in administrative expenses | Indicator | 2025 (RM'000) | 2024 (RM'000) | | :--- | :--- | :--- | | Revenue from contracts with customers | 55,511 | 49,624 | | Cost of services and sales | (45,587) | (38,929) | | Gross profit | 9,924 | 10,695 | | Other income and gains | 1,013 | 414 | | Selling and distribution expenses | (136) | (448) | | Administrative expenses | (174,031) | (8,290) | | Finance costs | (114) | (159) | | (Loss)/Profit before income tax | (163,344) | 2,212 | | Income tax expense | (1,988) | (1,191) | | (Loss)/Profit for the period | (165,332) | 1,021 | | (Loss)/Earnings per share attributable to equity holders of the Company (RM sen) | (5.75) | 0.04 | - Loss for the period: The Group turned from a profit of **RM1,021 thousand** in 2024 to a loss of **RM165,332 thousand** in 2025 [4](index=4&type=chunk)[5](index=5&type=chunk) - Administrative expenses significantly increased from **RM8,290 thousand** in 2024 to **RM174,031 thousand** in 2025 [4](index=4&type=chunk) [Unaudited Condensed Consolidated Statement of Financial Position](index=3&type=section&id=Unaudited%20Condensed%20Consolidated%20Statement%20of%20Financial%20Position) As of June 30, 2025, total assets decreased significantly to **RM142,846 thousand** from **RM311,662 thousand** on December 31, 2024, primarily due to a substantial reduction in goodwill within non-current assets, leading to a decrease in net assets from **RM295,176 thousand** to **RM128,235 thousand** | Indicator | June 30, 2025 (RM'000) | December 31, 2024 (RM'000) | | :--- | :--- | :--- | | **Assets** | | | | Non-current assets | 59,309 | 224,730 | | Goodwill | 27,818 | 191,911 | | Current assets | 83,537 | 86,932 | | Total assets | 142,846 | 311,662 | | **Equity and Liabilities** | | | | Current liabilities | 13,229 | 14,172 | | Non-current liabilities | 1,382 | 2,314 | | Total liabilities | 14,611 | 16,486 | | Net assets | 128,235 | 295,176 | | Capital and reserves attributable to equity holders of the Company | 123,763 | 290,485 | - Goodwill significantly decreased from **RM191,911 thousand** on December 31, 2024, to **RM27,818 thousand** on June 30, 2025 [6](index=6&type=chunk) - Total assets decreased from **RM311,662 thousand** on December 31, 2024, to **RM142,846 thousand** on June 30, 2025 [6](index=6&type=chunk) Notes to the Condensed Consolidated Interim Financial Information [General Information](index=5&type=section&id=General%20Information) C-Link Squared Limited, an exempted company incorporated in the Cayman Islands, primarily engages in investment holding, with no significant changes in the nature of its principal businesses during the reporting period - The Company is an exempted company incorporated in the Cayman Islands, with its principal activity being investment holding [8](index=8&type=chunk) - Principal subsidiary businesses include outsourced document management services in Malaysia, outsourced insurance risk analysis and marketing services in China, distribution and sales of medical equipment and pharmaceutical products, and internet hospital and physical clinic services [9](index=9&type=chunk) - There were no significant changes in the principal nature of the Group's businesses during the reporting period [10](index=10&type=chunk) [Basis of Preparation and Changes in Accounting Policies](index=5&type=section&id=Basis%20of%20Preparation%20and%20Changes%20in%20Accounting%20Policies) The Group's unaudited condensed consolidated interim financial information is prepared in accordance with IFRS and HKEX Listing Rules, with the first-time adoption of IAS 21 (Amendment) 'Lack of Exchangeability' having no material impact - The financial information is prepared in accordance with IFRS and the HKEX Listing Rules, is unaudited by external auditors, but has been reviewed by the Audit Committee [11](index=11&type=chunk)[12](index=12&type=chunk) - The Group first adopted IAS 21 (Amendment) 'Lack of Exchangeability', which specifies how an entity assesses whether a currency is exchangeable and determines the spot exchange rate, and requires additional disclosures [13](index=13&type=chunk) - These amendments had no significant impact on the Group's results and financial position for the current or prior periods [13](index=13&type=chunk) [Operating Segment Information](index=6&type=section&id=Operating%20Segment%20Information) The Group has only one reportable operating segment, outsourced services, which accounts for over 90% of revenue, with major revenue sources from Malaysia, Singapore, and China, and top five customers contributing 62.1% of total revenue - The Group has only one reportable operating segment: providing outsourced services, which accounts for over **90%** of total revenue [14](index=14&type=chunk) [Geographical Information](index=7&type=section&id=Geographical%20Information) The Group's revenue from external customers primarily originates from Malaysia, China, and Singapore, with Malaysia contributing **RM39,909 thousand** for the six months ended June 30, 2025 | Geographical Market | 2025 (RM'000) | 2024 (RM'000) | | :--- | :--- | :--- | | Malaysia | 39,909 | 34,446 | | Singapore | 1,889 | 1,413 | | China | 13,713 | 13,765 | | Total revenue from contracts with customers | 55,511 | 49,624 | [Non-current Assets](index=7&type=section&id=Non-current%20Assets) As of June 30, 2025, the Group's non-current assets totaled **RM58,637 thousand**, primarily located in Malaysia and China, with China's non-current assets significantly decreasing from December 31, 2024 | Region | June 30, 2025 (RM'000) | December 31, 2024 (RM'000) | | :--- | :--- | :--- | | Malaysia | 30,322 | 31,488 | | China | 28,315 | 192,667 | | Total | 58,637 | 224,155 | - Non-current assets in China significantly decreased from **RM192,667 thousand** on December 31, 2024, to **RM28,315 thousand** on June 30, 2025 [16](index=16&type=chunk) [Information about Major Customers](index=7&type=section&id=Information%20about%20Major%20Customers) For the six months ended June 30, 2025, the Group's top five customer groups, primarily banks and insurance groups, contributed **62.1%** of total revenue, with Bank Group A accounting for **20.9%** | Customer Group | Percentage of Total Revenue (2025) | Sales (2025, RM'000) | | :--- | :--- | :--- | | Bank Group A | 20.9% | 11,583 | | Bank Group B | 14.9% | 8,253 | | Insurance Group C | 10.8% | 5,987 | | Bank Group D | 8.0% | 4,444 | | Bank Group E | 7.5% | 4,174 | | Total | 62.1% | 34,441 | - The percentage of total revenue from the top five customer groups increased from **59.3%** in 2024 to **62.1%** in 2025 [17](index=17&type=chunk)[18](index=18&type=chunk) [Revenue from Contracts with Customers](index=8&type=section&id=Revenue%20from%20Contracts%20with%20Customers) For the six months ended June 30, 2025, total revenue was **RM55,511 thousand**, primarily from outsourced services (document management, insurance marketing, enterprise software solutions), accounting for **98.5%** of total revenue - Total revenue increased from **RM49,624 thousand** in 2024 to **RM55,511 thousand** in 2025 [19](index=19&type=chunk) - Outsourced services (document management, insurance marketing, enterprise software solutions) collectively accounted for approximately **98.5%** of total revenue [19](index=19&type=chunk) [Disaggregation of Revenue](index=8&type=section&id=Disaggregation%20of%20Revenue) Outsourced document management services revenue grew **17.9%** to **RM38,008 thousand**, while medical equipment distribution and sales revenue significantly decreased to **RM358 thousand** | Service Type | 2025 (RM'000) | 2024 (RM'000) | | :--- | :--- | :--- | | Outsourced document management | 38,008 | 32,247 | | Outsourced insurance marketing | 12,850 | 11,412 | | Customised software | 3,168 | 2,659 | | Electronic document storage services | 622 | 953 | | Medical equipment distribution and sales | 358 | – | | Sales of pharmaceutical products | – | 2,240 | | Internet hospital and physical clinic services | 505 | 113 | | Total revenue | 55,511 | 49,624 | - Revenue from medical equipment distribution and sales significantly decreased, primarily due to weaker consumer spending sentiment and stricter contract terms imposed by partner manufacturers [19](index=19&type=chunk) [Performance Obligations](index=9&type=section&id=Performance%20Obligations) The Group's performance obligations vary by service type, with outsourced document management, insurance marketing, and internet hospital services fulfilled at a point in time, while customized software and electronic document storage are fulfilled over time - Performance obligations for outsourced document management, insurance risk analysis, insurance marketing, internet hospital, and physical clinic services are satisfied at a point in time [20](index=20&type=chunk)[21](index=21&type=chunk)[25](index=25&type=chunk) - Performance obligations for customised software and electronic document storage services are satisfied over time [22](index=22&type=chunk)[23](index=23&type=chunk) - Performance obligations for medical equipment and pharmaceutical product distribution and sales are satisfied when customers accept the goods [24](index=24&type=chunk) [Other Income and Gains](index=10&type=section&id=Other%20Income%20and%20Gains) For the six months ended June 30, 2025, other income and gains significantly increased by **144.7%** to **RM1,013 thousand**, primarily due to higher net exchange gains | Indicator | 2025 (RM'000) | 2024 (RM'000) | | :--- | :--- | :--- | | Bank interest income | 404 | 381 | | Net exchange gains | 392 | 31 | | Others | 217 | 2 | | Total | 1,013 | 414 | - Other income and gains increased by **144.7%** from **RM414 thousand** in 2024 to **RM1,013 thousand** in 2025 [27](index=27&type=chunk) - Net exchange gains were the primary driver of this increase, rising from **RM31 thousand** to **RM392 thousand** [27](index=27&type=chunk) [Finance Costs](index=10&type=section&id=Finance%20Costs) For the six months ended June 30, 2025, finance costs decreased by **28.3%** to **RM114 thousand**, mainly due to reduced interest expenses on term loans | Item | 2025 (RM'000) | 2024 (RM'000) | | :--- | :--- | :--- | | Interest expense on term loans | 88 | 145 | | Interest expense on overdrafts | 3 | – | | Interest expense on lease liabilities | 23 | 14 | | Total | 114 | 159 | - Finance costs decreased by **28.3%** from **RM159 thousand** in 2024 to **RM114 thousand** in 2025 [28](index=28&type=chunk) [(Loss)/Profit Before Income Tax](index=11&type=section&id=Loss)%2FProfit%20Before%20Income%20Tax) For the six months ended June 30, 2025, the Group recorded a loss before income tax of **RM163,344 thousand**, a reversal from a profit of **RM2,212 thousand** in the prior period, primarily due to a **RM164,093 thousand** goodwill impairment loss | Item | 2025 (RM'000) | 2024 (RM'000) | | :--- | :--- | :--- | | Staff costs | 6,097 | 5,606 | | Depreciation of property, plant and equipment | 518 | 602 | | Depreciation of right-of-use assets | 269 | 209 | | Amortisation of intangible assets | 823 | 823 | | Expected credit loss (reversal)/provision for trade receivables | (224) | 167 | | Goodwill impairment loss | 164,093 | – | | Legal and other professional fees | 885 | 1,093 | | Software license fees | 2,571 | 237 | | Research and development expenses | 166 | 1,203 | - A goodwill impairment loss of **RM164,093 thousand** was the primary reason for the shift from profit to loss before income tax [29](index=29&type=chunk) [Income Tax Expense](index=11&type=section&id=Income%20Tax%20Expense) For the six months ended June 30, 2025, income tax expense increased by **66.9%** to **RM1,988 thousand**, mainly due to higher taxable income from outsourced document management services in Malaysia | Item | 2025 (RM'000) | 2024 (RM'000) | | :--- | :--- | :--- | | Current income tax — Malaysia | 1,517 | 1,087 | | Current income tax — China | 2 | 2 | | Deferred tax expense | 469 | 102 | | Total income tax expense | 1,988 | 1,191 | - Income tax expense increased by **66.9%** from **RM1,191 thousand** in 2024 to **RM1,988 thousand** in 2025 [30](index=30&type=chunk) [Interim Dividend](index=12&type=section&id=Interim%20Dividend) The Board does not recommend an interim dividend for the six months ended June 30, 2025, consistent with the prior period - The Board does not recommend an interim dividend for the six months ended June 30, 2025 (2024: nil) [31](index=31&type=chunk) [(Loss)/Earnings Per Share Attributable to Equity Holders of the Company](index=12&type=section&id=Loss)%2FEarnings%20Per%20Share%20Attributable%20to%20Equity%20Holders%20of%20the%20Company) For the six months ended June 30, 2025, basic loss per share attributable to equity holders was **RM5.75 sen**, a reversal from basic earnings per share of **RM0.04 sen** in the prior period, with basic and diluted figures being identical due to no potential dilutive shares | Indicator | 2025 (RM'000) | 2024 (RM'000) | | :--- | :--- | :--- | | (Loss)/Profit for the period attributable to equity holders of the Company | (165,305) | 1,118 | | Weighted average number of ordinary shares in issue ('000 shares) | 2,874,251 | 2,811,018 | | Basic and diluted (RM sen) | (5.75) | 0.04 | - Basic (loss)/earnings per share shifted from **RM0.04 sen** in 2024 to **(RM5.75) sen** in 2025 [5](index=5&type=chunk) - Basic and diluted (loss)/earnings per share are identical as the Group has no outstanding potential dilutive shares [34](index=34&type=chunk) [Goodwill](index=13&type=section&id=Goodwill) For the six months ended June 30, 2025, the Group recognized a goodwill impairment loss of approximately **RM164,093 thousand**, primarily due to the suspension of certain business items within the internet hospital and physical clinic services cash-generating unit, reducing net book value from **RM191,911 thousand** to **RM27,818 thousand** | Indicator | December 31, 2024 (RM'000) | June 30, 2025 (RM'000) | | :--- | :--- | :--- | | Net book value at beginning of period | 191,911 | 191,911 | | Impairment loss recognised | – | (164,093) | | Net book value at end of period | 191,911 | 27,818 | - A goodwill impairment loss of approximately **RM164,093 thousand** has been recognised in administrative expenses in the unaudited condensed consolidated statement of comprehensive income [35](index=35&type=chunk) - The impairment is primarily due to the suspension of certain business items within the cash-generating unit for internet hospital and physical clinic services [35](index=35&type=chunk) [Trade and Other Receivables](index=14&type=section&id=Trade%20and%20Other%20Receivables) As of June 30, 2025, net trade receivables decreased to **RM17,661 thousand**, while prepayments, deposits, and other receivables increased to **RM8,956 thousand**, with the majority of trade receivables due within one month | Item | June 30, 2025 (RM'000) | December 31, 2024 (RM'000) | | :--- | :--- | :--- | | Net trade receivables | 17,661 | 19,211 | | Prepayments, deposits and other receivables | 8,956 | 5,546 | | Total | 26,617 | 24,757 | | Ageing | June 30, 2025 (RM'000) | December 31, 2024 (RM'000) | | :--- | :--- | :--- | | Within 1 month | 10,953 | 10,521 | | 1 to 2 months | 2,834 | 3,636 | | 2 to 3 months | 2,187 | 2,752 | | Over 3 months | 1,687 | 2,302 | | Total | 17,661 | 19,211 | - Trade receivables are non-interest bearing and typically have a credit period of **30 days** [36](index=36&type=chunk) [Trade Payables](index=15&type=section&id=Trade%20Payables) As of June 30, 2025, total trade payables significantly increased to **RM3,192 thousand**, with a notable rise in payables due within one to three months | Item | June 30, 2025 (RM'000) | December 31, 2024 (RM'000) | | :--- | :--- | :--- | | Amounts due to third parties | 3,167 | 1,340 | | Amounts due to a related party | 25 | 65 | | Total | 3,192 | 1,405 | | Ageing | June 30, 2025 (RM'000) | December 31, 2024 (RM'000) | | :--- | :--- | :--- | | Within 1 month | 514 | 1,151 | | 1 to 2 months | 996 | 254 | | 2 to 3 months | 958 | – | | Over 3 months | 724 | – | | Total | 3,192 | 1,405 | - Total trade payables increased from **RM1,405 thousand** on December 31, 2024, to **RM3,192 thousand** on June 30, 2025 [38](index=38&type=chunk) [Share Capital](index=16&type=section&id=Share%20Capital) As of June 30, 2025, the Company's issued and fully paid share capital was **RM5,189 thousand**, comprising **2,874,251 thousand shares**, unchanged since the acquisition of Shengji Investment Limited in January 2024 | Item | Number of Shares ('000 shares) | HKD'000 | RM'000 | | :--- | :--- | :--- | :--- | | As at January 1, 2024 | 2,400,000 | 8,000 | 4,233 | | Acquisition of subsidiary | 474,251 | 1,581 | 956 | | As at December 31, 2024, January 1, 2025 and June 30, 2025 | 2,874,251 | 9,581 | 5,189 | - On January 26, 2024, the Group issued **474,251,497** shares of the Company to acquire the entire equity interest in Shengji Investment Limited [39](index=39&type=chunk) [Significant Related Party Transactions](index=17&type=section&id=Significant%20Related%20Party%20Transactions) The Group engaged in sales and purchases of goods and services with related parties and paid key management personnel compensation, with a decrease in purchases from Compugraphic Forms Sdn. Bhd. and a slight decrease in key management personnel remuneration [Purchase and Sale of Goods and Services](index=17&type=section&id=Purchase%20and%20Sale%20of%20Goods%20and%20Services) For the six months ended June 30, 2025, the Group's purchases of consumables from related company Compugraphic Forms Sdn. Bhd. decreased to **RM173 thousand** from **RM237 thousand** in the prior period | Item | 2025 (RM'000) | 2024 (RM'000) | | :--- | :--- | :--- | | Purchases of consumables from a related company, Compugraphic Forms Sdn. Bhd. | 173 | 237 | - Mr. Ling Sheng Shyan, a director of the Company, is a shareholder of Compugraphic Forms Sdn. Bhd., making it a related party to the Group [40](index=40&type=chunk) [Key Management Personnel Remuneration](index=17&type=section&id=Key%20Management%20Personnel%20Remuneration) For the six months ended June 30, 2025, total remuneration for the Group's key management personnel slightly decreased to **RM529 thousand** from **RM554 thousand** in the prior period | Item | 2025 (RM'000) | 2024 (RM'000) | | :--- | :--- | :--- | | Directors' fees | 258 | 278 | | Salaries, allowances and benefits in kind | 240 | 242 | | Contributions to retirement benefit schemes | 31 | 34 | | Total | 529 | 554 | Management Discussion and Analysis [Business Review and Outlook](index=18&type=section&id=Business%20Review%20and%20Outlook) The Group's core businesses include outsourced document management in Malaysia and internet hospital services in China, with a strategic shift towards multi-channel digital delivery and plans for data center expansion and market share growth in Southeast Asia and China - The Group's business model has transitioned from costly physical mail delivery to multi-channel digital delivery via IT software solutions [43](index=43&type=chunk) - The acquisition of **100%** equity in Shengji was completed on January 26, 2024, marking the Group's entry into China's internet hospital and physical clinic services business [45](index=45&type=chunk) [Business Overview and Transformation](index=18&type=section&id=Business%20Overview%20and%20Transformation) The Group provides outsourced document management in Malaysia and insurance risk analysis, medical distribution, and internet hospital services in China, actively pursuing digital transformation and expanding its healthcare business through acquisition - Outsourced document management services in Malaysia are the Group's largest revenue source, encompassing electronic document delivery, document printing, and mail delivery [42](index=42&type=chunk) - The Group has successfully developed proprietary IT-focused enterprise software applications, driving digital transformation in Malaysia's banking, insurance, and retail sectors [42](index=42&type=chunk) - Through the acquisition of Shengji, the Group entered China's internet hospital and physical clinic services market, offering virtual and physical healthcare services [45](index=45&type=chunk) [Future Plans and Prospects](index=19&type=section&id=Future%20Plans%20and%20Prospects) The Group plans to expand data processing and technological capabilities by converting an existing building into a new data center, expected to be operational by early 2027, and to increase market share in Malaysia, Singapore, Vietnam, and China, focusing on advanced internet cloud technology and big data analytics in China - Plans are underway to convert an existing building into a new data center to upgrade IT infrastructure and expand outsourced document management services and enterprise software solutions [46](index=46&type=chunk) - The data center is expected to be completed by the end of 2026 and operational by early 2027, enhancing document hosting capabilities [48](index=48&type=chunk) - In China, plans include developing advanced internet cloud technology and big data analytics to create service systems for insurance and insurance-related clients, exploring opportunities in insurance big data, health management, and SME data cloud services [49](index=49&type=chunk) [Financial Review](index=21&type=section&id=Financial%20Review) For the six months ended June 30, 2025, total revenue increased to **RM55.5 million**, but a significant goodwill impairment loss in administrative expenses led to a net loss for the period, with declining gross profit and margin, while other income and gains grew substantially due to net exchange gains - Total revenue was approximately **RM55.5 million**, primarily derived from outsourced services (accounting for **98.5%**) [50](index=50&type=chunk) - Loss for the period was approximately **RM165.3 million**, mainly due to a goodwill impairment loss of approximately **RM164.1 million** [64](index=64&type=chunk) [Revenue from Contracts with Customers](index=21&type=section&id=Revenue%20from%20Contracts%20with%20Customers) Total revenue grew to **RM55.5 million**, driven by increases in outsourced document management and insurance marketing services, while medical equipment and pharmaceutical product distribution sales significantly decreased due to weaker consumer sentiment and stricter contract terms | Service Type | 2025 (RM million) | 2024 (RM million) | Year-on-year Growth/Decrease | | :--- | :--- | :--- | :--- | | Outsourced document management services | 38.0 | 32.2 | +17.9% | | Outsourced insurance risk analysis and marketing services | 12.9 | 11.4 | +12.6% | | Enterprise software solutions | 3.8 | 3.6 | +4.9% | | Medical equipment and pharmaceutical product distribution and sales | 0.4 | 2.2 | -81.8% | | Internet hospital and physical clinic services | 0.5 | 0.1 | +400% | | Total revenue | 55.5 | 49.6 | +11.9% | - The decrease in revenue from medical equipment and pharmaceutical product distribution and sales was mainly due to weaker consumer spending sentiment and stricter contract terms imposed by partner manufacturers in China [54](index=54&type=chunk) [Cost of Services and Sales](index=23&type=section&id=Cost%20of%20Services%20and%20Sales) Cost of services and sales increased by **17.1%** to **RM45.6 million**, primarily due to higher postage costs incurred for mail delivery services in Malaysia | Indicator | 2025 (RM million) | 2024 (RM million) | Year-on-year Growth | | :--- | :--- | :--- | :--- | | Cost of services and sales | 45.6 | 38.9 | +17.1% | - The increase in costs was mainly due to higher postage incurred for mail delivery services in Malaysia [56](index=56&type=chunk) [Gross Profit and Gross Margin](index=23&type=section&id=Gross%20Profit%20and%20Gross%20Margin) Gross profit decreased by **7.2%** to **RM9.9 million**, and gross margin declined by **3.7 percentage points** to **17.9%**, primarily due to an increased proportion of lower-margin mail delivery service revenue | Indicator | 2025 (RM million) | 2024 (RM million) | Year-on-year Change | | :--- | :--- | :--- | :--- | | Gross profit | 9.9 | 10.7 | -7.2% | | Gross margin | 17.9% | 21.6% | -3.7 percentage points | - The decrease in gross margin was mainly due to an increased proportion of revenue from lower-margin mail delivery services, driven by higher unit prices charged for these services [57](index=57&type=chunk) [Other Income and Gains](index=24&type=section&id=Other%20Income%20and%20Gains) Other income and gains significantly increased by **144.7%** to **RM1.0 million**, primarily driven by higher net exchange gains | Indicator | 2025 (RM million) | 2024 (RM million) | Year-on-year Growth | | :--- | :--- | :--- | :--- | | Other income and gains | 1.0 | 0.4 | +144.7% | - The main reason for the increase was net exchange gains [58](index=58&type=chunk) [Selling and Distribution Expenses](index=24&type=section&id=Selling%20and%20Distribution%20Expenses) Selling and distribution expenses decreased to **RM0.1 million**, primarily comprising promotional expenses in China and staff costs for outsourced insurance risk analysis, insurance marketing, and medical equipment distribution and sales | Indicator | 2025 (RM million) | 2024 (RM million) | | :--- | :--- | :--- | | Selling and distribution expenses | 0.1 | 0.4 | [Administrative Expenses](index=24&type=section&id=Administrative%20Expenses) Administrative expenses significantly increased by **1,999.3%** to **RM174.0 million**, primarily due to the recognition of approximately **RM164.1 million** in goodwill impairment loss | Indicator | 2025 (RM million) | 2024 (RM million) | Year-on-year Growth | | :--- | :--- | :--- | :--- | | Administrative expenses | 174.0 | 8.3 | +1,999.3% | - Primarily due to a goodwill impairment loss of approximately **RM164.1 million** related to the cash-generating unit for internet hospital and physical clinic services in China [60](index=60&type=chunk) [Finance Costs](index=24&type=section&id=Finance%20Costs) Finance costs decreased by **28.3%** to **RM114 thousand**, mainly due to a reduction in the outstanding balance of term loans | Indicator | 2025 (RM'000) | 2024 (RM'000) | Year-on-year Decrease | | :--- | :--- | :--- | :--- | | Finance costs | 114 | 159 | -28.3% | - Mainly due to a decrease in the outstanding balance of the Group's term loans [61](index=61&type=chunk) [(Loss)/Profit Before Income Tax](index=24&type=section&id=Loss)%2FProfit%20Before%20Income%20Tax) The Group shifted from a profit before income tax of **RM2.2 million** in 2024 to a loss of **RM163.3 million** in 2025, primarily due to a goodwill impairment loss | Indicator | 2025 (RM million) | 2024 (RM million) | | :--- | :--- | :--- | | (Loss)/Profit before income tax | (163.3) | 2.2 | - The shift from profit to loss was primarily due to a goodwill impairment loss of approximately **RM164.1 million** [62](index=62&type=chunk) [Income Tax Expense](index=25&type=section&id=Income%20Tax%20Expense) Income tax expense increased by **66.9%** to **RM2.0 million**, mainly due to higher taxable income from outsourced document management services in Malaysia | Indicator | 2025 (RM million) | 2024 (RM million) | Year-on-year Growth | | :--- | :--- | :--- | :--- | | Income tax expense | 2.0 | 1.2 | +66.9% | - Mainly due to an increase in taxable income from outsourced document management services in Malaysia [63](index=63&type=chunk) [(Loss)/Profit for the Period](index=25&type=section&id=Loss)%2FProfit%20for%20the%20Period) The Group shifted from a profit for the period of **RM1.0 million** in 2024 to a loss of **RM165.3 million** in 2025, primarily due to a goodwill impairment loss | Indicator | 2025 (RM million) | 2024 (RM million) | | :--- | :--- | :--- | | (Loss)/Profit for the period | (165.3) | 1.0 | - The shift from profit to loss was primarily due to a goodwill impairment loss of approximately **RM164.1 million** [64](index=64&type=chunk) [Goodwill and Impairment Loss of Goodwill](index=25&type=section&id=Goodwill%20and%20Impairment%20Loss%20of%20Goodwill) The Group recognized a goodwill impairment loss of approximately **RM164.1 million** as of June 30, 2025, primarily related to the acquisition of Shengji Group's internet hospital and physical clinic services business, due to its underperformance against expectations amid economic downturns and market challenges - As of June 30, 2025, the goodwill impairment loss for the Shengji Group cash-generating unit was approximately **RM164,093 thousand** [66](index=66&type=chunk) - The impairment loss was primarily due to Shengji Group's financial performance not meeting the cash flow forecasts as of December 31, 2024 [70](index=70&type=chunk) [Background Information](index=25&type=section&id=Background%20Information) The Company completed the acquisition of **100%** equity in Shengji Group on January 26, 2024, for an consideration share fair value of approximately **RM232,349 thousand**, recognizing goodwill of approximately **RM215,234 thousand** related to its internet hospital and physical clinic services in China - The acquisition of **100%** of Shengji Group's issued shares was completed on January 26, 2024; Shengji Group primarily provides internet hospital and physical clinic services in China [65](index=65&type=chunk) - Goodwill of approximately **RM215,234 thousand** was recognized on the completion date [65](index=65&type=chunk) [Goodwill Impairment Loss as at June 30, 2025](index=26&type=section&id=Goodwill%20Impairment%20Loss%20as%20at%20June%2030%2C%202025) As of June 30, 2025, the suspension of certain business items within Shengji Group's cash-generating unit led to a goodwill impairment loss of approximately **RM164,093 thousand**, reducing the net book value to **RM27,818 thousand**, with recoverability assessed using the value-in-use method under IAS 36 | Indicator | Goodwill as at June 30, 2025 (after impairment loss, RM'000) | Goodwill as at December 31, 2024 (net of impairment loss, RM'000) | Goodwill impairment loss for the six months ended June 30, 2025 (RM'000) | | :--- | :--- | :--- | :--- | | Shengji Group cash-generating unit | 27,818 | 191,911 | 164,093 | - A goodwill impairment loss of approximately **RM164,093 thousand** has been recognised and included in administrative expenses in the unaudited condensed consolidated statement of comprehensive income [35](index=35&type=chunk) - The impairment assessment was conducted in accordance with IAS 36 'Impairment of Assets', with the recoverable amount measured by estimating the value in use of the Shengji Group cash-generating unit to which goodwill is allocated [66](index=66&type=chunk)[67](index=67&type=chunk) [Valuation Methodology](index=27&type=section&id=Valuation%20Methodology) The valuer used the income approach (discounted cash flow method) to determine the value in use of the Shengji Group cash-generating unit, based on five-year financial budgets and management's future business outlook, in compliance with IFRS 13 'Fair Value Measurement' - The valuer adopted the income approach to arrive at the value in use of the cash-generating unit, which discounts future cash flows to a single current amount [68](index=68&type=chunk) - The valuation is based on financial budgets covering a five-year period, with key assumptions including growth rates, discount rates, and management's views on future business prospects [68](index=68&type=chunk) [Key Valuation Assumptions](index=27&type=section&id=Key%20Valuation%20Assumptions) Valuation assumptions include formal approvals, reasonable financial forecasts, sufficient technical personnel, stable tax laws, and no significant adverse political, legal, economic, or financial changes; however, Shengji Group's actual financial performance fell short due to economic downturns, reduced consumer spending, stricter cooperation terms, regulatory changes, increased competition, and slower healthcare investment - Key assumptions include: all relevant legal approvals and business certificates will be formally obtained and renewed; forecasts in the financial information are reasonable and will be achieved; there is an adequate supply of technical personnel; and no significant changes will occur in tax laws, tax rates, political, legal, economic, or financial conditions [69](index=69&type=chunk)[71](index=71&type=chunk) - Shengji Group's financial performance fell short of expectations due to: reduced online sales of pharmaceutical and health products from economic downturns and stricter cooperation terms; decreased demand for insurance marketing services due to reduced corporate budgets and increased competition; health consulting services affected by regulatory policy changes and macroeconomic environment; medical equipment sales impacted by supply chain instability, raw material price fluctuations, and slower industry investment; and offline sales of pharmaceutical and health products affected by policy adjustments and reduced consumption [70](index=70&type=chunk)[72](index=72&type=chunk) - Based on cash flow forecasts, the recoverable amount of Shengji Group's cash-generating unit as of June 30, 2025, was approximately **RM28,300 thousand**, resulting in a recognized goodwill impairment loss of approximately **RM164,093 thousand** [73](index=73&type=chunk) [Interim Dividend](index=30&type=section&id=Interim%20Dividend) The Board does not recommend an interim dividend for the six months ended June 30, 2025, consistent with the prior period - The Board does not recommend an interim dividend for the six months ended June 30, 2025 (2024: nil) [74](index=74&type=chunk) [Liquidity and Financial Resources](index=30&type=section&id=Liquidity%20and%20Financial%20Resources) As of June 30, 2025, total loans and borrowings decreased by **31.0%** to approximately **RM3.0 million**, with cash and bank balances at approximately **RM54.6 million**, maintaining a robust financial position with a current ratio of approximately **6.3 times** | Indicator | June 30, 2025 (RM million) | December 31, 2024 (RM million) | Year-on-year Change | | :--- | :--- | :--- | :--- | | Total loans and borrowings | 3.0 | 4.3 | -31.0% | | Cash and bank balances | 54.6 | 59.7 | -8.5% | | Current ratio | 6.3 times | 6.1 times | +0.2 times | - Loans and borrowings bear interest at floating rates ranging from **4.75%** to **6.85%** and are denominated in Ringgit [75](index=75&type=chunk) - The Group maintains a sound financial position, with a net current asset position, capable of meeting its day-to-day operational obligations [76](index=76&type=chunk) [Contingent Liabilities](index=30&type=section&id=Contingent%20Liabilities) As of June 30, 2025, the Group had no significant contingent liabilities - As of June 30, 2025, the Group had no significant contingent liabilities [77](index=77&type=chunk) [Capital Commitments](index=31&type=section&id=Capital%20Commitments) As of June 30, 2025, the Group's capital commitment for converting an existing building into a data center was approximately **RM0.1 million**, to be funded by proceeds from share offer and internal resources | Item | June 30, 2025 (RM million) | December 31, 2024 (RM million) | | :--- | :--- | :--- | | Capital commitment for data center conversion | 0.1 | Nil | - The capital commitment will be funded by proceeds from the Group's share offer and internal resources [78](index=78&type=chunk) [Funding and Treasury Policy](index=31&type=section&id=Funding%20and%20Treasury%20Policy) The Group adopts a prudent financial management approach, maintaining a healthy liquidity position and closely monitoring liquidity risks, without using any risk hedging instruments for the six months ended June 30, 2025 - The Group adopts a prudent financial management approach, maintaining a healthy liquidity position [79](index=79&type=chunk) - The Board closely monitors the Group's liquidity position to ensure it can meet its funding requirements [79](index=79&type=chunk) - For the six months ended June 30, 2025, the Group did not use any risk hedging instruments [79](index=79&type=chunk) [Foreign Exchange Risk](index=31&type=section&id=Foreign%20Exchange%20Risk) Operating primarily in Malaysia and China, with transactions settled in Ringgit, Singapore Dollars, and Renminbi, the Board believes future foreign exchange fluctuations will not significantly impact operations and has not adopted a formal hedging policy or used derivative contracts for the six months ended June 30, 2025 - The Group primarily operates in Malaysia and China, with most transactions settled in Ringgit, Singapore Dollars, and Renminbi [80](index=80&type=chunk) - The Board believes that future foreign exchange fluctuations will not have any significant impact on the Group's operations [80](index=80&type=chunk) - For the six months ended June 30, 2025, the Group did not use any derivative contracts to hedge foreign exchange risk, nor has it adopted a formal hedging policy [80](index=80&type=chunk) [Gearing Ratio](index=31&type=section&id=Gearing%20Ratio) As of June 30, 2025, the Group's gearing ratio increased to approximately **2.4%** from **1.5%** on December 31, 2024, primarily due to a reduction in total equity attributable to equity holders of the Company caused by a goodwill impairment loss | Indicator | June 30, 2025 | December 31, 2024 | | :--- | :--- | :--- | | Gearing ratio | 2.4% | 1.5% | - The increase in the gearing ratio was primarily attributable to a decrease in total equity attributable to equity holders of the Company, due to a goodwill impairment loss of approximately **RM164.1 million** [81](index=81&type=chunk) [Material Investments, Material Acquisitions and Disposals](index=32&type=section&id=Material%20Investments%2C%20Material%20Acquisitions%20and%20Disposals) For the six months ended June 30, 2025, the Group had no material investments, acquisitions, or disposals of subsidiaries, associates, or joint ventures - The Group's management adopts a prudent investment strategy, utilizing surplus cash to generate stable interest income from low-risk investment products [82](index=82&type=chunk) - For the six months ended June 30, 2025, the Group had no material investments, nor did it undertake any material acquisitions or disposals [82](index=82&type=chunk) [Future Plans for Material Investments and Capital Assets](index=32&type=section&id=Future%20Plans%20for%20Material%20Investments%20and%20Capital%20Assets) Except as disclosed in the 'Share Issue and Use of Proceeds from Share Offer' section of this announcement, the Group has no other future plans for material investments and capital assets as of the date of this announcement - Except for the share issue and use of proceeds from the share offer, the Group has no other future plans for material investments and capital assets as of the date of this announcement [83](index=83&type=chunk) [Purchase, Sale or Redemption of the Company's Shares](index=32&type=section&id=Purchase%2C%20Sale%20or%20Redemption%20of%20the%20Company%27s%20Shares) For the six months ended June 30, 2025, neither the Company nor its subsidiaries purchased, sold, or redeemed any of the Company's listed securities, and the Company held no treasury shares - For the six months ended June 30, 2025, neither the Company nor any of its subsidiaries purchased, sold, or redeemed any of the Company's listed securities [84](index=84&type=chunk) - As of June 30, 2025, and the date of this announcement, the Company held no treasury shares [84](index=84&type=chunk) [Events After the Reporting Period](index=32&type=section&id=Events%20After%20the%20Reporting%20Period) Except as disclosed in this announcement, the Group had no significant events after June 30, 2025, up to the date of this announcement - Except as disclosed in this announcement, the Group had no significant events after June 30, 2025, up to the date of this announcement [85](index=85&type=chunk) [Employees and Remuneration Policy](index=32&type=section&id=Employees%20and%20Remuneration%20Policy) As of June 30, 2025, the Group had approximately **192 employees** with total remuneration costs of approximately **RM6.1 million**, and its remuneration policy is based on qualifications, performance, market trends, and operating results, offering discretionary bonuses, share options, and other benefits | Indicator | June 30, 2025 | June 30, 2024 | | :--- | :--- | :--- | | Number of employees | 192 | 173 | | Total staff costs (RM million) | 6.1 | 5.6 | - The remuneration policy is formulated based on employees' qualifications, capabilities, work performance, industry experience, relevant market trends, and the Group's operating results [87](index=87&type=chunk) - Discretionary bonuses and other benefits are provided, including share options, retirement benefits, medical subsidies, pensions, and training programs [87](index=87&type=chunk) [Share Option Scheme](index=33&type=section&id=Share%20Option%20Scheme) The Company adopted a share option scheme on March 11, 2020, but no share options have been granted under the scheme since its adoption - The Company adopted a share option scheme on March 11, 2020 [88](index=88&type=chunk) - Since its adoption, the Company has not granted any share options under the share option scheme [88](index=88&type=chunk) [Share Issue and Use of Proceeds from Share Offer](index=33&type=section&id=Share%20Issue%20and%20Use%20of%20Proceeds%20from%20Share%20Offer) The Company raised net proceeds of approximately **HKD73.7 million** from its 2020 share offer, with funds reallocated for purposes such as acquiring and converting an existing building into a data center, and for software development and marketing, with **HKD36.1 million** utilized and **HKD37.6 million** unutilized as of June 30, 2025 - Net proceeds from the share offer amounted to approximately **HKD73.7 million** [89](index=89&type=chunk) - The use of proceeds has been changed multiple times, including reallocating funds originally for data center construction to acquire an existing building and convert it into a data center [89](index=89&type=chunk)[90](index=90&type=chunk) | Purpose | Approximate Percentage of Total Net Proceeds | Proposed Use (Approx. HKD million) | Actual Amount of Net Proceeds Utilised as at June 30, 2025 (Approx. HKD million) | Actual Amount of Net Proceeds Unutilised as at June 30, 2025 (Approx. HKD million) | Expected Timeline for Utilisation of Unutilised Net Proceeds | | :--- | :--- | :--- | :--- | :--- | :--- | | To enhance technical capabilities and develop other vertical/parallel market capabilities | 89.8% | 66.2 | (30.3) | 35.9 | | | — To acquire an existing building and convert it into a Tier 2 data center and upgrade IT infrastructure | 76.7% | 56.5 | (20.6) | 35.9 | December 31, 2026 | | — To engage external software development vendors and develop new applications under the software development plan | 13.1% | 9.7 | (9.7) | – | | | To expand local market share and explore regional expansion to further capture market share | 10.2% | 7.5 | (5.8) | 1.7 | | | — To increase the Group's marketing and promotion efforts to acquire new customers | 10.2% | 7.5 | (5.8) | 1.7 | December 31, 2025 | | Total | 100.0% | 73.7 | (36.1) | 37.6 | | [Issue of Securities](index=36&type=section&id=Issue%20of%20Securities) During the reporting period, the Company did not issue any securities for cash or sell any treasury shares - During the reporting period, the Company did not issue any of its securities for cash or sell any treasury shares for cash [94](index=94&type=chunk) Corporate Governance [Standard Code for Securities Transactions by Directors](index=36&type=section&id=Standard%20Code%20for%20Securities%20Transactions%20by%20Directors) The Company adopted the Standard Code as its code of conduct for directors' securities transactions, with all directors confirming compliance and no breaches by employees for the six months ended June 30, 2025 - The Company has adopted the Standard Code as set out in Appendix C3 of the Listing Rules as its code of conduct for directors' securities transactions [95](index=95&type=chunk) - All directors confirmed compliance with the Standard Code for the six months ended June 30, 2025 [95](index=95&type=chunk) - The Company found no instances of employees breaching the Standard Code [95](index=95&type=chunk) [Code on Corporate Governance Practices](index=36&type=section&id=Code%20on%20Corporate%20Governance%20Practices) For the six months ended June 30, 2025, the Company complied with all applicable provisions of the Corporate Governance Code, except for the combined roles of Chairman and CEO held by Mr. Ma Shengcong, which the Board deems in the best interest of the Company and its shareholders - The Company complied with all applicable code provisions of the Corporate Governance Code, except for the combined roles of Chairman and Chief Executive Officer held by Mr. Ma Shengcong, which deviates from code provision C.2.1 [96](index=96&type=chunk)[97](index=97&type=chunk) - The Board believes that Mr. Ma Shengcong's dual role is most suitable, and the current arrangement is beneficial and in the overall interest of the Company and its shareholders [97](index=97&type=chunk) - The Board will review the effectiveness of its structure and composition from time to time based on prevailing circumstances and consider separating the roles of Chairman and Chief Executive Officer at an appropriate juncture [98](index=98&type=chunk) [Audit Committee and Review of Interim Results](index=38&type=section&id=Audit%20Committee%20and%20Review%20of%20Interim%20Results) The Audit Committee, comprising three independent non-executive directors chaired by Mr. Yang Junhui, reviewed the Group's accounting principles, policies, and interim financial information, confirming compliance with relevant standards, though the interim financial information was not audited or reviewed by an independent auditor - The Audit Committee comprises three independent non-executive directors, with Mr. Yang Junhui serving as Chairman [99](index=99&type=chunk) - The Audit Committee has reviewed the accounting principles and policies adopted by the Group, as well as the Company's unaudited condensed consolidated interim financial information and interim results announcement for the six months ended June 30, 2025 [99](index=99&type=chunk) - The Company's unaudited condensed consolidated interim financial information for the six months ended June 30, 2025, has not been audited or reviewed by the Company's independent auditor [99](index=99&type=chunk) [Publication of Interim Results Announcement and Interim Report](index=38&type=section&id=Publication%20of%20Interim%20Results%20Announcement%20and%20Interim%20Report) This interim results announcement has been published on the HKEX and Company websites, with the full interim report containing all information required by the Listing Rules to be dispatched to shareholders and published on relevant websites in due course - This interim results announcement is published on the HKEX website (http://www.hkexnews.hk) and the Company's website (http://www.clinksquared.com) [100](index=100&type=chunk) - The Group's interim report for the six months ended June 30, 2025, containing all information required by the Listing Rules, will be dispatched to shareholders in due course in accordance with the Listing Rules and the Company's corporate communication arrangements [100](index=100&type=chunk) [Board Information](index=38&type=section&id=Board%20Information) As of the date of this announcement, the Board comprises executive directors Mr. Ma Shengcong and Ms. Zhang Ying; non-executive directors Mr. Ling Sheng Shyan and Dr. Wu Xianyi; and independent non-executive directors Mr. Yang Junhui, Mr. Qian Jianguang, and Mr. Xie Yaozu - Executive Directors are Mr. Ma Shengcong and Ms. Zhang Ying [102](index=102&type=chunk) - Non-executive Directors are Mr. Ling Sheng Shyan and Dr. Wu Xianyi [102](index=102&type=chunk) - Independent Non-executive Directors are Mr. Yang Junhui, Mr. Qian Jianguang, and Mr. Xie Yaozu [102](index=102&type=chunk)

Core Viewpoint - C-LINK SQ (01463) anticipates a significant net loss attributable to shareholders of approximately 167 million Malaysian Ringgit for the first half of 2025, primarily due to goodwill impairment related to its cash-generating units in China [1] Financial Performance - For the six months ending June 30, 2024, the company expects to report a net profit attributable to shareholders of approximately 1.1 million Malaysian Ringgit [1] - The expected net loss in 2025 is largely attributed to a goodwill impairment loss of about 165.9 million Malaysian Ringgit, based on preliminary independent valuations conducted by an independent valuation firm [1]

Core Viewpoint - C-LINK SQ (01463) anticipates a significant net loss attributable to shareholders of approximately 167 million Malaysian Ringgit in the first half of 2025, primarily due to goodwill impairment related to its cash-generating units in China [1] Financial Performance - For the six months ending June 30, 2024, the company expects to report a net profit attributable to shareholders of approximately 1.1 million Malaysian Ringgit [1] - The expected net loss in 2025 is largely attributed to a goodwill impairment loss of about 165.9 million Malaysian Ringgit, based on preliminary independent valuations conducted by an independent valuation firm [1]